Shay Capital’s Apellis Pharmaceuticals APLS Stock Holding History

Shay Capital’s Portfolio APLS Stock Details APLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,347	Closed	-$416K	–	493
2026 Q1	$416K	Buy	+10,347	New	+$223K	0.03%	294

Other funds holding APLS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Shay Capital's APLS Position: Q2 2026 in Review

Shay Capital sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 10,347 shares — an estimated $416K sold.

Shay Capital first reported a position in APLS in Q1 2026 and held it in 1 quarter. The position peaked at $416K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

Shay Capital reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Shay Capital sold 10,347 Apellis Pharmaceuticals shares in Q2 2026, an estimated $416K.
Shay Capital first reported a position in Apellis Pharmaceuticals in Q1 2026 and held it in 1 quarter.
Shay Capital's Apellis Pharmaceuticals position peaked at $416K in Q1 2026.
1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Shay Capital's 13F filing for Q2 2026, filed 14 Aug 2026.